FENG CHI BIOTECH CORPFF

FENG CHI BIOTECH CORP

17.90TWDR
0.000.00%
At close at May 29, 03:22 GMT
TWD
No trades
See on Supercharts

6744 fundamentals

Key facts

Market capitalization‪262.95 M‬TWD
Founded1992
CEOHung Ming Chang
About

Feng Chi Biotech Corp. engages in the provision of neonatal genetic disease testing, new born screening, life science and microbiological testing services. It focuses on colorectal cancer, lung cancer; scientific research genetic testing and development. The company was founded on May 12, 1992 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪262.95 M‬‬
Price to earning ratio (P/E)
16.68x
Price to sales ratio (P/S)
1.62x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
16.68x
Price to sales ratio (P/S)
1.62x
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪5.00‬
‪10.00‬
‪15.00‬
‪20.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪8.0%‬
‪9.6%‬
‪11.2%‬
‪12.8%‬
‪14.4%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
‪‪100.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪21.00 M‬‬
‪‪42.00 M‬‬
‪‪63.00 M‬‬
‪‪84.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪21.00 M‬‬
‪‪42.00 M‬‬
‪‪63.00 M‬‬
‪‪84.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Reagent
Medical Technology
Instrument and Parts
Maintenance Service
By country
Period: 2024
Taiwan
Other

Dividends

Dividend yield, history and sustainability

Dividend summary
88.17%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
5.87%
Last payment
1.05
Last ex-date
Jul 22, 2024
Last pay date
Aug 12, 2024
Dividend history
‪3.5%‬
‪4.4%‬
‪5.3%‬
‪6.2%‬
‪7.1%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.35‬
‪0.70‬
‪1.05‬
‪1.40‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪17.00 M‬‬
‪‪34.00 M‬‬
‪‪51.00 M‬‬
‪‪68.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬
Assets
Liabilities